| Opioid receptors and signaling on cells from the immune system JM Bidlack, M Khimich, AL Parkhill, S Sumagin, B Sun, CM Tipton Journal of Neuroimmune Pharmacology 1, 260-269, 2006 | 102 | 2006 |
| A transgender health care panel discussion in a required diversity course AL Parkhill, JL Mathews, S Fearing, J Gainsburg American Journal of Pharmaceutical Education 78 (4), 81, 2014 | 67 | 2014 |
| Role-reversal exercise with deaf strong hospital to teach communication competency and cultural awareness JL Mathews, AL Parkhill, DA Schlehofer, MJ Starr, S Barnett American Journal of Pharmaceutical Education 75 (3), 53, 2011 | 65 | 2011 |
| High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2 JE Hilbert, RJ Barohn, PR Clemens, EA Luebbe, WB Martens, ... Neurology 89 (13), 1348-1354, 2017 | 57 | 2017 |
| Oral mucositis and stomatitis associated with conventional and targeted anticancer therapy A Parkhill Journal of Pharmacovigilance 1 (3), 1, 2013 | 53 | 2013 |
| Several δ-opioid receptor ligands display no subtype selectivity to the human δ-opioid receptor AL Parkhill, JM Bidlack European journal of pharmacology 451 (3), 257-264, 2002 | 44 | 2002 |
| Assay of G Protein-Coupled Receptor Activation of G Proteins in Native Cell Membranes Using [35S]GTPγS Binding JM Bidlack, AL Parkhill G Protein Signaling: Methods and Protocols, 135-143, 2004 | 40 | 2004 |
| Redefining the Structure−Activity Relationships of 2,6-Methano-3-benzazocines. 4. Opioid Receptor Binding Properties of 8-[N-(4‘-phenyl)-phenethyl)carboxamido … MP Wentland, M VanAlstine, R Kucejko, R Lou, DJ Cohen, AL Parkhill, ... Journal of medicinal chemistry 49 (18), 5635-5639, 2006 | 30 | 2006 |
| The language of texting: Altering English or a language of its own? E Gorney The Review: A Journal of Undergraduate Student Research 13 (1), 39-42, 2012 | 28 | 2012 |
| Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50, 488 in a mouse monocyte-like cell line AL Parkhill, JM Bidlack International immunopharmacology 6 (6), 1013-1019, 2006 | 25 | 2006 |
| Lesbian, gay, bisexual, and transgender inclusion: survey of campus climate in colleges and schools of pharmacy AN Jacobson, KL Matson, JL Mathews, AL Parkhill, TA Scartabello Currents in Pharmacy Teaching and Learning 9 (1), 60-65, 2017 | 19 | 2017 |
| The need for transgender health content in the pharmacy curriculum AL Parkhill, J Gainsburg, S Fearing, JL Mathews INNOVATIONS in pharmacy 2 (4), 2011 | 16 | 2011 |
| Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy BP Fitzgerald, KM Conn, J Smith, A Walker, AL Parkhill, JE Hilbert, ... Journal of neurology 263, 2528-2537, 2016 | 10 | 2016 |
| Ιnnovations in teaching: Role-Reversal Exercise with Deaf Strong Hospital to Teach Communication, Competency and Cultural Awareness J Mathews, A Parkhill, D Schlehofer, M Starr, S Barnett American Journal of Pharmaceutical Education 75 (3), 2011 | 4 | 2011 |
| Course-Level Curriculum Map Pilot Program JM Souza, J Mathews, AL Parkhill | 2 | 2012 |
| WSOP prescription for innovation—use as needed (PRN) ME Lull, CR Birnie, L Chablani, KA Connor, A Corigliano, VS Dave, ... | 1 | 2013 |
| CE Credits-Pediatric and Adolescent Sports-Related Injuries and Ailments-It is important for the pharmacist to have an understanding of the common musculoskeletal and … AL Parkhill, J Mathews, NR Blanchard US Pharmacist 34 (3), 44, 2009 | 1 | 2009 |
| LGBTQ+ Cultural Awareness and Best Practices Continuing Education for Pharmacists and Pharmacy Technicians A Parkhill Postgraduate Healthcare Education, LLC, 2019 | | 2019 |
| Assessment of Depression Onset and Prevalence in Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSDH) A Parkhill, E Cusack | | 2019 |
| Assessment of the Use of Non-Pharmacological Methods for Managing Depression in Patients with Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD) M Roberts, AL Parkhill, D Skalla, K Miller | | 2018 |
